Scarica l'app Stockscreener
17.78
5.02%
0.84
Dopo l'orario di chiusura:
17.78
Caredx Inc Borsa (CDNA) Ultime notizie
Press Release Distribution & PR Platform - ACCESS Newswire
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News - GuruFocus
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Eagle-Tribune
CareDx Strengthens Leadership: New Chief Product Officer Joins with Performance-Based Equity Package - Stock Titan
Lobbying Update: $50,000 of CAREDX INC. lobbying was just disclosed - Nasdaq
CareDx Officer Sells Shares to Satisfy Tax Obligations - TradingView
CareDx's secretary and general counsel sells shares worth $16,373 By Investing.com - Investing.com India
CareDx’s secretary and general counsel sells shares worth $16,373 - Investing.com Australia
CareDx's secretary and general counsel sells shares worth $16,373 - Investing.com
CareDx CFO Abhishek Jain sells shares worth $4,695 - Investing.com
Healthcare Tech Pioneer CareDx Set to Unveil Q1 2025 Performance Data - Stock Titan
CareDx to Report First Quarter 2025 Financial Results - The Joplin Globe
Prudential Financial Inc. Purchases 103,862 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx CFO secures new severance agreement terms - Investing.com Australia
CareDx CFO secures new severance agreement terms By Investing.com - Investing.com South Africa
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - Business Wire
CareDx Updates CFO Severance Agreement Amid Leadership Changes - TipRanks
CareDx Inc (CDNA) Shares Gap Down to $18.22 on Mar 26 - GuruFocus
CareDx Releases Two Expanded Indications for AlloSure Testing Services - Medical Product Outsourcing
SHAREHOLDER ALERT: Kaskela Law LLC Announces Class Action - GlobeNewswire
Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra
Trend Tracker for (CDNA) - news.stocktradersdaily.com
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta - Benzinga
CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - PR Newswire
CareDx Launches Two Expanded Indications for AlloSure Testing Services - Diagnostic and Interventional Cardiology
CareDx, Inc (NASDAQ:CDNA) Shares Bought by US Bancorp DE - Defense World
CareDx: Some Litigation Clouds Have Cleared - Seeking Alpha
CareDx director George Bickerstaff sells $367,102 in common stock - Investing.com India
CareDx Director Makes Significant Stock Sale! - TipRanks
CareDx director George Bickerstaff sells $367,102 in common stock By Investing.com - Investing.com UK
Why CareDx's (NASDAQ:CDNA) Earnings Are Weaker Than They Seem - simplywall.st
Major Breakthrough: CareDx AlloSure Now Covers Infant Heart and Dual-Organ Transplant Testing - Stock Titan
Principal Financial Group Inc. Has $406,000 Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance
HC Wainwright Has Negative Estimate for CareDx Q1 Earnings - Defense World
(CDNA) On The My Stocks Page - news.stocktradersdaily.com
Rhumbline Advisers Boosts Stake in CareDx, Inc (NASDAQ:CDNA) - Defense World
New York State Common Retirement Fund Sells 15,584 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx (NASDAQ:CDNA) Trading Down 7.9% Following Analyst Downgrade - Defense World
CareDx stock price target cut to $25 at H.C. Wainwright By Investing.com - Investing.com Canada
CareDx (NASDAQ:CDNA) Price Target Cut to $25.00 by Analysts at HC Wainwright - Defense World
CareDx stock price target cut to $25 at H.C. Wainwright - Investing.com
Where CareDx Stands With Analysts - Benzinga
CareDx, Inc (NASDAQ:CDNA) Shares Sold by ARK Investment Management LLC - MarketBeat
CareDx (NASDAQ:CDNA) Shares Gap Up Following Strong Earnings - Defense World
Decoding CareDx Inc (CDNA): A Strategic SWOT Insight - GuruFocus.com
CareDx (NASDAQ:CDNA) Upgraded by StockNews.com to "Buy" Rating - MarketBeat
6.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):